BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31801574)

  • 1. Microscopic tumor spread beyond (echo)endoscopically determined tumor borders in esophageal cancer.
    Machiels M; van Montfoort ML; Thuijs NB; van Berge Henegouwen MI; Alderliesten T; Meijer SL; van Hooft JE; Hulshof MCCM
    Radiat Oncol; 2019 Dec; 14(1):219. PubMed ID: 31801574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual tumor after neoadjuvant chemoradiation outside the radiation therapy target volume: a new prognostic factor for survival in esophageal cancer.
    Muijs C; Smit J; Karrenbeld A; Beukema J; Mul V; van Dam G; Hospers G; Kluin P; Langendijk J; Plukker J
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):845-52. PubMed ID: 24411191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced inter-observer and intra-observer delineation variation in esophageal cancer radiotherapy by use of fiducial markers.
    Machiels M; Jin P; van Hooft JE; Gurney-Champion OJ; Jelvehgaran P; Geijsen ED; Jeene PM; Willemijn Kolff M; Oppedijk V; Rasch CRN; van Herk MB; Alderliesten T; Hulshof MCCM
    Acta Oncol; 2019 Jun; 58(6):943-950. PubMed ID: 30905243
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of endoscopically determined gross tumor volume and metabolic tumor volume in esophageal cancer.
    Lee TH; Ryoo HG; Lee R; Paeng JC; Chung H; Kim HJ
    Medicine (Baltimore); 2021 Jun; 100(24):e26338. PubMed ID: 34128879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definitive or neoadjuvant chemoradiotherapy for squamous cell oesophageal cancer?
    Ilson D; Lordick F
    Lancet Oncol; 2018 Oct; 19(10):1285-1286. PubMed ID: 30528077
    [No Abstract]   [Full Text] [Related]  

  • 6. Residual tumor characteristics of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy.
    Tang H; Jiang D; Zhang S; Zeng Z; Tan L; Hou Y; Wang Q; ; Wang H; Zhu J; Shen Y; Yin J; Ge D
    J Thorac Cardiovasc Surg; 2021 Dec; 162(6):1632-1641. PubMed ID: 33268125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.
    Noordman BJ; Spaander MCW; Valkema R; Wijnhoven BPL; van Berge Henegouwen MI; Shapiro J; Biermann K; van der Gaast A; van Hillegersberg R; Hulshof MCCM; Krishnadath KK; Lagarde SM; Nieuwenhuijzen GAP; Oostenbrug LE; Siersema PD; Schoon EJ; Sosef MN; Steyerberg EW; van Lanschot JJB;
    Lancet Oncol; 2018 Jul; 19(7):965-974. PubMed ID: 29861116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locoregional Residual Esophageal Cancer after Neo-adjuvant Chemoradiotherapy and Surgery Regarding Anatomic Site and Radiation Target Fields: A Histopathologic Evaluation Study.
    Faiz Z; Kats-Ugurlu G; Mui VEM; Karrenbeld A; Burgerhof HGM; Plukker JTM; Muijs CT
    Ann Surg; 2022 Jun; 275(6):e759-e765. PubMed ID: 32740246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response.
    Blackham AU; Yue B; Almhanna K; Saeed N; Fontaine JP; Hoffe S; Shridhar R; Frakes J; Coppola D; Pimiento JM
    J Surg Oncol; 2015 Nov; 112(6):597-602. PubMed ID: 26394724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual esophageal cancer after neoadjuvant chemoradiotherapy frequently involves the mucosa and submucosa.
    Shapiro J; ten Kate FJ; van Hagen P; Biermann K; Wijnhoven BP; van Lanschot JJ
    Ann Surg; 2013 Nov; 258(5):678-88; discussion 688-9. PubMed ID: 24096766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual Cancer Volume Predicts Clinical Outcome in Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy.
    Nakao R; Konishi E; Fujiwara H; Otsuji E; Yokota I; Urata Y; Yanagisawa A
    Int J Surg Pathol; 2019 Oct; 27(7):713-721. PubMed ID: 31203677
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic relevance of serial endoscopic ultrasound after chemoradiation in esophageal cancer.
    Bohle W; Kasper M; Zoller WG
    Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Relevance of Lymph Node Regression After Neoadjuvant Chemoradiation for Esophageal Cancer.
    Philippron A; Bollschweiler E; Kunikata A; Plum P; Schmidt C; Favi F; Drebber U; Hölscher AH
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):549-558. PubMed ID: 28043475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional Radiotherapy With or Without Chemotherapy Following Endoscopic Resection for Stage I Esophageal Carcinoma: A Pilot Study.
    Yang X; Men Y; Wang J; Kang J; Sun X; Zhao M; Sun S; Yuan M; Bao Y; Ma Z; Wang G; Hui Z
    Technol Cancer Res Treat; 2021; 20():15330338211048051. PubMed ID: 34657505
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor Remission and Tumor-Infiltrating Lymphocytes During Chemoradiation Therapy: Predictive and Prognostic Markers in Locally Advanced Esophageal Squamous Cell Carcinoma.
    Qian D; Wang Y; Zhao G; Cao F; Er P; Chen X; Cheng J; Zhang W; Li X; Zhang B; Guan Y; Zhou D; Wang J; Jiang H; Yu Z; Yuan Z; Wang P; Pang Q
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):319-328. PubMed ID: 31228553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
    Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN
    Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life During and After Completion of Neoadjuvant Chemoradiotherapy for Esophageal and Junctional Cancer.
    Noordman BJ; Verdam MGE; Onstenk B; Heisterkamp J; Jansen WJBM; Martijnse IS; Lagarde SM; Wijnhoven BPL; Acosta CMM; van der Gaast A; Sprangers MAG; van Lanschot JJB
    Ann Surg Oncol; 2019 Dec; 26(13):4765-4772. PubMed ID: 31620943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation field size and dose determine oncologic outcome in esophageal cancer.
    Gemici C; Yaprak G; Batirel HF; Ilhan M; Mayadagli A
    World J Surg Oncol; 2016 Oct; 14(1):263. PubMed ID: 27737673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual carcinoma cells after chemoradiotherapy for esophageal squamous cell carcinoma patients: striving toward appropriate judgment of biopsy.
    Fujishima F; Taniyama Y; Nakamura Y; Okamoto H; Ozawa Y; Ito K; Ishida H; Konno-Kumagai T; Kasajima A; Taniuchi S; Watanabe M; Kamei T; Sasano H
    Dis Esophagus; 2018 Jul; 31(7):. PubMed ID: 29346536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal adenocarcinoma stage III: Survival based on pathological response to neoadjuvant treatment.
    Schwameis K; Zehetner J; Hagen JA; Oh DS; Worrell SG; Rona K; Cheng N; Samaan J; Green KM; Lipham JC
    Surg Oncol; 2017 Dec; 26(4):522-526. PubMed ID: 29113673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.